First Time Loading...

Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 14.89 USD 0.95%
Updated: May 10, 2024

Verona Pharma PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Verona Pharma PLC
Revenue Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Revenue
£30.7B
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
2%
AstraZeneca PLC
LSE:AZN
Revenue
$47.6B
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
6%
Indivior PLC
LSE:INDV
Revenue
$1.1B
CAGR 3-Years
19%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Revenue
$2.9B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
8%
Dechra Pharmaceuticals PLC
LSE:DPH
Revenue
£761.5m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
15%

See Also

What is Verona Pharma PLC's Revenue?
Revenue
0 USD

Based on the financial report for Dec 31, 2023, Verona Pharma PLC's Revenue amounts to 0 USD.